BKB Growth Investments, LLC 3/A
3/A · Verrica Pharmaceuticals Inc. · Filed Feb 2, 2026
Insider Transaction Report
Form 3/AAmended
BKB Growth Investments, LLC
10% Owner
Holdings
Series B Warrants (right to buy)
[F3][F1][F2]Exercise: $13.35Exp: 2029-11-22→ Common Stock (224,719 underlying)
Footnotes (3)
- [F1]Immediately exercisable.
- [F2]The Reporting Person will not be entitled to exercise any portion of a Series B Warrant that, upon giving effect to such exercise, would cause the aggregate number of shares beneficially owned by the Reporting Person to exceed 19.99% of the number of shares of the Issuer's common stock outstanding immediately after giving effect to the exercise.
- [F3]The exercise price on the original Form 3 did not account for the 1-for-10 reverse stock split of the Issuer's common stock that went into effect on July 24, 2025.
Signature
BKB Growth Investments, LLC, By: Tiger Lily Capital, LLC, its manager By: /s/ Paul Manning, its manager|2026-02-02